U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

E&BI Frameworks Lead - Advanced Therapies

Regulatory Compliance & EthicsUpdated on Nov 14
Full-time$148k - $195k

About the Job

Requirements

  • A bachelor's degree in a relevant field.
  • At least 8 years of compliance, ethics, legal, audit, or risk experience.
  • Significant experience within the life sciences industry.
  • Experience supporting clinical-stage development activities.
  • Knowledge of U.S. healthcare compliance requirements.
  • Experience with risk assessments, monitoring, and training programs.

Responsibilities

  • Serve as the primary ethics and compliance advisor to business leaders.
  • Lead risk assessments and mitigation planning activities.
  • Design Ethics and Business Integrity processes for research and development teams working on advanced therapies.
  • Advise on research, development, medical, and regulatory activities.
  • Develop and execute risk-based compliance program initiatives.
  • Deliver training and communications that promote ethical decision-making.
  • Monitor program effectiveness and drive continuous improvement.

Desired Qualifications

  • An advanced degree in law, compliance, life sciences, or business.
  • Professional certification in ethics and compliance.
  • Experience supporting biotechnology or advanced therapy programs.
  • Experience working within global, matrixed organizations.
  • Strong executive communication and stakeholder management skills.
  • Demonstrated ability to build and enhance compliance programs.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs